1Viazzi F, Leoncini G, Ratto E, et al, Vascular permeability, blood pressure, and organ damage in primary hypertension. Hypertens Res, 2008,31 : 873-879.
3Eguchi K, Pickering TG, Hoshide S, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/ without type 2 diabetes. Am J Hypertens, 2005,21 : 443-450.
4Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measure ment of blood pressure at home: correlation with target organ damage. J Hypertens, 2008,26: 1919-1927.
5Hansen TW, Li Y, Staessen JA. Blood pressure variability remains an elusive predictor of cardio-vascular outcome. Am J Hypertens, 2009,22:3-4.
6Torun D, Sezer S, Arat Z, et al. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Int Heart J, 2005,46 : 1073-1082.
7Pickering T. Schwartz J, Verdecchia P, et al. Prediction of strokes versus cardiac events by ambulatory monitoring of blood pressure: results from an international database. Blood Press Monit, 2007,12:397-399.
8Rodendanz AR. Hypertension and chronic renal insufficiency. Acta Med AustRiaca, 2001,28: 66-69.
10Segura J, Campo C, Gil P, et al. Development of chronic kidney disease and cardiovascular prognosis in essential hypeaensive patients. J Am Soc Nephrol, 2004, 15:1616-1622.
2Kim S,Ohta K,Hamaguchi A,et al.Contribution of renal a ngiotensin Ⅱ type I receptor to gene expressions in hypertension-induced renal injury.Kidney Int,1994,46:995-997.
3Bianchi S,Bigazzi R,Baldari G,et al.Diurnal variation of blood pressure and microalbuminuria in essential hypertensi on.Am J Hypertens,1994,7:23.
4Staessen JA,Wang JG,Ginocchio G.The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk.J Hypertens,1997,15:1579-1592.
5Bonnardeaux A,Davies E,Jeunemaitre X,et al.A ngiotensin Ⅱ type 1 receptor gene polymorphisms in human essential hypertension.Hypertension,1994,24:63-69.
6Giner V,Poch E,Bragulat E,et al.Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension.Hypertension,2000,35:512-517.
7Castellano M,Moirsan ML,Beschi M.Angiotensin Ⅱ type 1 polymorphism relationships with blood pressure and cardiovascular structure.Hypertension,1996,28:1076-1080.
4Cuspidi C,Macca G,Sampieri L,et al.Target organ damage and nondipping pqttern defined by two sessions of mbulatory blood pressure monitoring in recently diagnosed essential hypertensive patients[J].J Hypertens,2001,19(3):1539-1545.
5The International Society of Hypertension and the Eurpean Society of Hypertension.2003 guidelines for management of hypertension[J].J Hypertens,2003,21:1011-1053.
6Zamora CR,Cubeddu LX.Microalbum innria dowe need a new threshold[J].Hum Hynertens,2009,23(2):146-149.
7SU DF,Miao CY.Blood pressure variability and organ damage[J].2001,28(9): 709-715.
8Wyszynska T,Cichocka E,Wieteska-Klimczak A,et al.A sing1e pediatric center experience with 1025 children with hypertension.Acta Paediatr,1992,81:244-246.
9Daniels SB,Loggie JM,McEnery PT,et al.Clinical spectrum of intrinsic renovascular hypertension in children.Pediatrics,1987,80:698-704.
10Deal JE,Snell MF,Barratt TM,et al.Renovascular disease in childhood.J Pediatr,1992,121:378-384.
